Vasoactive drugs in circulatory shock

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 7, 2011, Pages 847-855

  Hollenberg, Steven M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Dopamine; Inotropic; Norepinephrine; Shock; Vasopressor

Indexed keywords

ADRENALIN; DIGOXIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; ISOPRENALINE; LEVOSIMENDAN; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PROLACTIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN;

ADRENERGIC ACTIVITY; BLOOD PRESSURE; CARDIOGENIC SHOCK; CELL METABOLISM; CORONARY ARTERY CONSTRICTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FLUID RESUSCITATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPOTENSION; ILEUS; IMMUNE DEFICIENCY; INTESTINE INFARCTION; LACTIC ACIDOSIS; LOADING DRUG DOSE; LOW DRUG DOSE; MALABSORPTION; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; OXYGEN SATURATION; POINT OF CARE TESTING; PRIORITY JOURNAL; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPTIC SHOCK; SHOCK; SIDE EFFECT; SPLANCHNIC BLOOD FLOW; STRESS ULCER; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC HEART FAILURE; TACHYCARDIA; TISSUE BLOOD FLOW; TISSUE OXYGENATION; TISSUE PERFUSION; VASOCONSTRICTION; VASODILATATION;

CARDIOTONIC AGENTS; CRITICAL CARE; DOPAMINE; FEMALE; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS; MALE; NOREPINEPHRINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SHOCK; SHOCK, CARDIOGENIC; SHOCK, HEMORRHAGIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 79953311526     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201006-0972CI     Document Type: Review

References (96)

1. Hollenberg SM, Parrillo JE. Shock. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison's principles of internal medicine, 14th ed. New York: McGraw-Hill; 1997. pp. 214-222.
2. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006;34:1333-1337.
3. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27:1369-1377. (Pubitemid 29379377)
4. Fink MP. Bench-to-bedside review: cytopathic hypoxia. Crit Care 2002;6:491-499. (Pubitemid 35414580)
5. + ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005;365:871-875.
6. Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B, Hollenberg SM, Parrillo JE. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007;33:970-977. (Pubitemid 46835396)
7. Vincent JL, Dufaye P, Berre J. Serial lactate determinations during circulatory shock. Crit Care Med 1983;11:449-451. (Pubitemid 13057566)
8. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010;303:739-746.
9. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
10. Reinhart K, Kuhn HJ, Hartog C, Bredle DL. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 2004;30:1572-1578. (Pubitemid 39094958)
11. Varpula M, Karlsson S, Ruokonen E, Pettila V. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med 2006;32:1336-1343. (Pubitemid 44267921)
12. 2 uptake during bacteremia in the dog. J Appl Physiol 1987;63:1487-1489.
13. 2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998;157:1219-1225.
14. De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91-99. (Pubitemid 38037403)
15. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL, Arnold RC, Colilla S, Zanotti S, Hollenberg SM. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007;49:88-98, e1-e2.
16. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32:1825-1831. (Pubitemid 39202356)
17. Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M, Abate NL, Shapiro NI, Parrillo JE, Hollenberg SM. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34:2210-2217.
18. Creteur J, De Backer D, Sakr Y, Koch M, Vincent JL. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 2006;32:516-523.
19. Weil MH, Shubin H. Proposed reclassification of shock states with special reference to distribution defects. In: Hinshaw LN, Cox BG, editors. The fundamental mechanisms of shock. New York: Plenum Press; 1972. pp. 13-23.
20. Hollenberg SM. Recognition and treatment of cardiogenic shock. Semin Respir Crit Care Med 2004;25:661-671. (Pubitemid 40041586)
21. Antonelli M, Levy M, Andrews PJ, Chastre J, Hudson LD, Manthous C, Meduri GU, Moreno RP, Putensen C, Stewart T, Torres A. Hemodynamic monitoring in shock and implications for management: International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 2007;33:575-590.
22. Cohn JN. Blood pressure measurement in shock: mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 1967;199:118-122.
23. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004;32:1928-1948.
24. Bersten AD, Holt AW. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995;3:650-661.
25. Kirchheim HR, Ehmke H, Hackenthal E, Lowe W, Persson P. Autoregulation of renal blood flow, glomerular filtration rate and renin release in conscious dogs. Pflugers Arch 1987;410:441-449. (Pubitemid 18029394)
26. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873. (Pubitemid 38344143)
27. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000;28:2729-2732.
28. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005;33:780-786.
29. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989;17:426-429. (Pubitemid 19136909)
30. Martin C, Saux P, Eon B, Aknin P, Gouin F. Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990;34:413-417. (Pubitemid 20310371)
31. Schreuder WO, Schneider AJ, Groeneveld ABJ, Thijs LG. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 1989;95:1282-1288.
32. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-1357. (Pubitemid 24323617)
33. Martin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990;18:282-285. (Pubitemid 20086856)
34. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A, Sporn P. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993;19:151-154. (Pubitemid 23193707)
35. Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993;21:1296-1303. (Pubitemid 23270498)
36. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993;103:1826-1831. (Pubitemid 23174321)
37. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997;23:282-287. (Pubitemid 27129993)
38. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986;18:141-155. (Pubitemid 16181521)
39. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000;28:2758-2765.
40. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003;31:1659-1667.
41. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-789.
42. Hoogenberg K, Smit AJ, Girbes ARJ. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 1998;26:260-265. (Pubitemid 28082686)
43. Neviere R, Chagnon JL, Vallet B, Lebleu N, Marechal X, Mathieu D, Wattel F, Dupuis B. Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock. Crit Care Med 1997;25:1371-1377. (Pubitemid 27347303)
44. Guerin JP, Levraut J, Samat-Long C, Leverve X, Grimaud D, Ichai C. Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 2005;23:18-24. (Pubitemid 40083022)
45. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J; Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 2000;356:2139-2143. (Pubitemid 32047951)
46. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006;34:589-597.
47. Povoa PR, Carneiro AH, Ribeiro OS, Pereira AC. Influence of vasopressor agent in septic shock mortality: results from the Portuguese Community-acquired Sepsis Study (SACiUCI study). Crit Care Med 2009;37:410-416.
48. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-1590.
49. Oberbeck R, Schmitz D, Wilsenack K, Schuler M, Husain B, Schedlowski M, Exton MS. Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med 2006;32:731-739.
50. Lipman J, Roux A, Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991;19:61-65.
51. Wilson W, Lipman J, Scribante J, Kobiliski S, Lee C, Krause P, Cooper J, Barr J. Septic shock: does adrenaline have a role as a first-line inotropic agent? Anaesth Intens Care 1992;20:470-474.
52. Moran JL, O'Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P. Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 1993;21:70-77. (Pubitemid 23028478)
53. Mackenzie SJ, Kapadia F, Nimmo GR, Armstrong IR, Grant IS. Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med 1991;17:36-39.
54. Le Tulzo Y, Seguin P, Gacouin A, Camus C, Susprin E, Jouannic I, Thomas R. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary study. Intensive Care Med 1997;23:664-670. (Pubitemid 27312046)
55. Day NP, Phu NH, Bethell DP, Mai NT, Chau TT, Hien TT, White NJ. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996;348:219-223. (Pubitemid 26254195)
56. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997;25:399-404. (Pubitemid 27152731)
57. Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 2002;23:654-658. (Pubitemid 34733331)
58. Martikainen TJ, Tenhunen JJ, Giovannini I, Uusaro A, Ruokonen E. Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO2 content gradients and lactate-to-pyruvate ratios. Am J Physiol Gastrointest Liver Physiol 2005;288:G586-G592. (Pubitemid 40261759)
59. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002;71:381-388. (Pubitemid 34518149)
60. Seguin P, Laviolle B, Guinet P, Morel I, Malledant Y, Bellissant E. Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. Crit Care 2006;10:R32.
61. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008;34:2226-2234.
62. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troche G, Ricard JD, Nitenberg G, Papazian L, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007;370:676-684. (Pubitemid 47299251)
63. Morelli A, Lange M, Ertmer C, Dunser M, Rehberg S, Bachetoni A, D'Alessandro M, Van Aken H, Guarracino F, Pietropaoli P, et al. Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study. Shock 2008;29:446-451. (Pubitemid 351416797)
64. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 2008;12:R143.
65. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989-1002. (Pubitemid 32885477)
66. Barrett BJ, Parfrey PS. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-386. (Pubitemid 43145062)
67. Abboud FM, Floras JS, Aylward PE, Guo GB, Gupta BN, Schmid PG. Role of vasopressin in cardiovascular and blood pressure regulation. Blood Vessels 1990;27:106-115. (Pubitemid 20365763)
68. Wang BC, Flora-Ginter G, Leadley RJ Jr, Goetz KL. Ventricular receptors stimulate vasopressin release during hemorrhage. Am J Physiol 1988;254:R204-R211.
69. Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, D'Allesandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-1125. (Pubitemid 27097820)
70. Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, Paillard M, Raphael JC, Gajdos P, Annane D. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002;30:497-500. (Pubitemid 34214607)
71. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003;31:1752-1758. (Pubitemid 36714233)
72. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-1282. (Pubitemid 27347289)
73. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA III. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001;29:487-493. (Pubitemid 32225288)
74. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001;27:1416-1421. (Pubitemid 32758942)
75. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582. (Pubitemid 34193495)
76. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-2319. (Pubitemid 36578501)
77. Albanese J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 2005;33:1897-1902. (Pubitemid 41306507)
78. van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003;124:2256-2260. (Pubitemid 38010597)
79. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A. High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003;31:2646-2650. (Pubitemid 37455414)
80. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887. (Pubitemid 351397087)
81. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984;100:483-490. (Pubitemid 14126735)
82. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R, Group SC. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-1032.
83. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994;330:1717-1722. (Pubitemid 24171030)
84. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, et al. ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2004;110:588-636.
85. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
86. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216. (Pubitemid 40348525)
87. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-1547. (Pubitemid 34269999)
88. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003;41:997-1003. (Pubitemid 36315544)
89. Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock: a prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996;109:1302-1312. (Pubitemid 26145670)
90. Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Soffker G, Lemm H, Swyter M, Wegener N, Winkler M, et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007;35:2732-2739. (Pubitemid 350175769)
91. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Ferrer-Hita JJ, Abreu-Gonzalez P, Munoz MB. Cardiogenic shock after primary percutaneous coronary intervention: effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail 2006;8: 723-728. (Pubitemid 44637270)
92. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007;297:1883-1891. (Pubitemid 46707842)
93. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005;31:638-644. (Pubitemid 40684980)
94. Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Carbone I, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006;34:2287-2293. (Pubitemid 44260011)
95. Vincent JL, editor. Critical care medicine: Churchill's ready reference. Philadelphia: Churchill Livingstone/Elsevier; 2009. pp. 12-13.
96. Hollenberg SM, Parrillo JE. Acute heart failure and shock. In: Crawford MH, DeMarco J, Paulus WJ, editors. Cardiology, 3rd ed. Philadelphia: Mosby; 2010. p. 964.